Zack Rosenbloom, a recent graduate of Tulane University with a double major in Management and Legal Studies in Business and Cell and Molecular Biology, has a strong educational foundation for a promising career. With experience from working in various industries and serving different roles, Zack's expertise lies in delivering medical and biological expertise into the larger business as well as the greater healthcare community.

Zack's experience as a Rare Disease Medical Affairs intern at Pfizer allowed him to learn how to create value for patients by delivering medical and biological expertise into the larger business. From there, he worked as a business analyst on a consulting project at Tefen, learning how to manage and create an efficient value chain for a small-company through waste reduction and process improvements in operations. Afterward, he took on the role of Medical Project Manager at Trois Prime, ensuring that client timelines are adhered to and all relevant parties got what they needed on their ends while logging information on their project management end. He then went back to Pfizer and supported Market Access and HEOR teams of the Global Rare Disease PHI Business Unit, creating timelines and templates for various projects, managing the budget, collecting meeting minutes, and helping with RWD, RWE, and business development projects.

In addition to his work experience, Zack has also studied Oncology and Cancer Biology, Non-Credit Summer Class at Emory University and Biology/Biological Sciences, General at King's College London.

Currently, Zack serves as the COO and Senior Pandemic Response Advisor at Bidversity. With his impressive educational background and diverse professional experience, Zack Rosenbloom is poised to make significant contributions in a variety of industries.